Blog

Photo of Manni Mohyuddin from www.mdedge.com

Jul 7, 2024, 17:38

Some myeloma updates by Manni Mohyuddin

Manni Mohyuddin shared on X:

“Thanks again to Medscape for the opportunity to write about some myeloma updates at ASCO24.

I focus on the return of belantamab, and the use of quads in newly diagnosed myeloma.

ASCO 2024: Treating Myeloma Just Got More Complicated.”

Source: Manni Mohyuddin/X

Dr. Manni Mohyuddin is an Assistant Professor at the Huntsman Cancer Institute, University of Utah, specializing in oncology. He is mainly interested in myeloma, supportive care, end-of-life management, and implementing cost-effective, evidence-based treatment strategies.

ASCO 2024 ASCO24 belantamab cancer cancer treatment Manni Mohyuddin Medscape multiple myeloma myeloma research myeloma updates newly diagnosed myeloma OncoDaily Oncology quads

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology